1. Home
  2. Labeler Index
  3. Physicians Total Care, Inc.
  4. NDC Product Code: 54868-2221 Imipramine Hydrochloride

NDC 54868-2221 Imipramine Hydrochloride

View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. Product Characteristics
  4. What is NDC 54868-2221?
  5. Imipramine Hydrochloride Uses
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk

Product Information

This product is EXCLUDED from the official NDC directory because the listing certification is expired.
NDC Product Code:
54868-2221
Proprietary Name:
Imipramine Hydrochloride
Product Type: [3]
EXPIRED PRODUCT and EXCLUDED from the NDC Directory
Labeler Name: [5]
Physicians Total Care, Inc.
Labeler Code:
54868
Product Label ID:
f1cfdf51-5211-4b31-9ac0-d06a3997ac8c
Start Marketing Date: [9]
11-12-1992
Listing Expiration Date: [11]
12-31-2017
Exclude Flag: [12]
E
Code Structure:
Code Navigator:

Product Characteristics

Color(s):
YELLOW (C48330 - YELLOW)
GREEN (C48329 - GREEN)
BROWN (C48332 - REDDISH BROWN)
Shape:
ROUND (C48348)
Size(s):
5 MM
7 MM
9 MM
Imprint(s):
V11;LU
V12;LU
V13;LU
Score:
1

Product Packages

NDC Code 54868-2221-3

Package Description: 30 TABLET, FILM COATED in 1 BOTTLE

Product Details

What is NDC 54868-2221?

The NDC code 54868-2221 is assigned by the FDA to the product Imipramine Hydrochloride which is product labeled by Physicians Total Care, Inc.. The product's dosage form is . The product is distributed in a single package with assigned NDC code 54868-2221-3 30 tablet, film coated in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Imipramine Hydrochloride?

The concomitant use of monoamine oxidase inhibiting compounds is contraindicated. Hyperpyretic crises or severe convulsive seizures may occur in patients receiving such combinations. The potentiation of adverse effects can be serious, or even fatal. When it is desired to substitute imipramine hydrochloride tablets in patients receiving a monoamine oxidase inhibitor, as long an interval should elapse as the clinical situation will allow, with a minimum of 14 days. Initial dosage should be low and increases should be gradual and cautiously prescribed.The drug is contraindicated during the acute recovery period after a myocardial infarction. Patients with a known hypersensitivity to this compound should not be given the drug. The possibility of cross-sensitivity to other dibenzazepine compounds should be kept in mind.

Which are Imipramine Hydrochloride UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Imipramine Hydrochloride Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Imipramine Hydrochloride?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".